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Serogroup classifications based upon the O-somatic antigen of Shiga toxin-producing
Escherichia coli (STEC) provide significant epidemiological information on clinical isolates. Each
O-antigen determinant is encoded by a unique cluster of genes present between the gnd and
galF chromosomal genes. Alternatively, serogroup-specific polymorphisms might be encoded in
loci that are encoded outside of the O-antigen gene cluster. Segments of the core bacterial
loci mdh, gnd, gcl, ppk, metA, ftsZ, relA and metG for 30 O26 STEC strains have previously been
sequenced, and comparative analyses to O157 distinguished these two serogroups. To
screen these loci for serogroup-specific traits within a broader range of clinically significant
serogroups, DNA sequences were obtained for 19 strains of 10 additional STEC serogroups.
Unique alleles were observed at the gnd locus for each examined STEC serogroup, and this
correlation persisted when comparative analyses were extended to 144 gnd sequences from 26
O-serogroups (comprising 42 O:H-serotypes). These included O157, O121, O103, O26,
O5:non-motile (NM), O145:NM, O113:H21, O111:NM and O117:H7 STEC; and
furthermore, non-toxin encoding O157, O26, O55, O6 and O117 strains encoded distinct gnd
alleles compared to STEC strains of the same serogroup. DNA sequencing of a 643 bp region of
gnd was, therefore, sufficient to minimally determine the O-antigen of STEC through molecular
means, and the location of gnd next to the O-antigen gene cluster offered additional support
for the co-inheritance of these determinants. The gnd DNA sequence-based serogrouping
method could improve the typing capabilities for STEC in clinical laboratories, and was used
successfully to characterize O121:H19, O26:H11 and O177:NM clinical isolates prior to
serological confirmation during outbreak investigations.
INTRODUCTION
Shiga toxin-producing Escherichia coli (STEC) are bacterial
pathogens that result in both outbreak and sporadic occur-
rences of human mortality and disease. Symptoms can
include bloody and non-bloody diarrhoea, and children are
susceptible to renal failure due to haemolytic uraemic
syndrome.STECare transmitted tohumansbyconsumption
of contaminated food or water, person-to-person contact or
animal-to-person contact, where natural reservoirs include
cattle, pigs and sheep (Karch et al.,2 0 0 5 ) .S e r o g r o u p
classifications based upon the O-somatic or H-flagellar
antigens of STEC provide significant epidemiological
information on clinical isolates, and this measure can
provide the first indication of relatedness between strains
during outbreak investigations. The serogroup is also
indicative of the overall genetic relatedness between E. coli
strains, including virulence gene content, such as the locus
forenterocyteeffacement(LEE)pathogenicityisland,andthe
stx1 and stx2 loci encoding Shiga toxins (Prager et al., 2005;
Girardeau et al., 2005; Karmali et al., 2003).
Abbreviations: LEE, locus for enterocyte effacement; NM, non-motile;
STEC, Shiga toxin-producing Escherichia coli.
The GenBank/EMBL/DDBJ accession numbers for the nucleotide
sequences reported in this paper are DQ472524–DQ472651.
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clinically in North America is O157 (Johnson et al., 2006);
however, biased sampling likely results from the availability
of clinical media and detection reagents that target this
serogroup. Directed studies for the isolation and char-
acterization of both O157 and non-O157 STEC from
clinical samples have indicated that the proportion of non-
O157 in North America is likely higher than clinical
records have indicated (Thompson et al., 2005; Jelacic et al.,
2003; Fey et al., 2000). In Canada, over 90% of STEC
strains detected are serotype O157:H7 or O157:non-
motile (NM) (Woodward et al., 2002). The global
prevalence of non-O157 includes significant outbreaks of
O26, O121, O103, O111 and O145, and in some countries
it is recognized that these serogroups exceed the prevalence
of O157 STEC (Karch et al., 2005). Furthermore, non-
O157 strains have been identified along with O157 strains
in clinical samples (Paton et al., 1996), so it is possible that
a diagnostic bias towards O157 may prevent the detection
of the aetiological STEC serogroup during human illness.
Molecular methods for the characterization and identifica-
tion of O-antigen determinants have been devised using
restriction profiling and allele-specific PCR. The entire O-
antigen-encoding gene cluster could be amplified using
primers that targeted conserved regions in the neighbour-
ing gnd sequence (encoding 6-phosphogluconate dehydro-
genase) and JUMPstart sequence, and enzymic digestion of
this amplicon identified RFLPs correlating to O-antigen
determinants (Coimbra et al., 2000). This method was
problematic due to the length of the amplicon (upwards of
20 kbp) and the absence of unique restriction profiles for
all serotypes. Within the O-antigen gene cluster the wzx
and wzy loci encode the O-antigen flippase and polymer-
ase, respectively, and distinct alleles corresponding to each
O-serogroup have been used for molecular serogrouping of
O103, O157, O26, O113 and O111 strains (Perelle et al.,
2005; DebRoy et al., 2004; Paton & Paton, 1999a;
Fratamico et al., 2005; D’Souza et al., 2002). It has been
suggested that these assays could replace traditional
serological methods (DebRoy et al., 2005); however, the
individual tests currently detect only one to three O-
serogroups. In the absence of a priori knowledge of a
serogroup, a large number of reagents may be required to
confirm serogroup identity with these methods. Robust
platforms such as DNA microarrays containing wzx and
wzy probes targeting up to four E. coli serogroups are
currently being investigated (Liu & Fratamico, 2006), and
broad subtyping of STEC has been achieved using allelic
variants of a LEE-encoded determinant (Gilmour et al.,
2006).
Multilocus sequence typing has been attempted for each of
the STEC serotypes O26:H11, O121:H19, O103:H2 or
O157:H7, but this method was not appropriate for
subtyping because very few polymorphisms were observed
between strains of the same serotype (Gilmour et al., 2005;
Tarr et al., 2002; Noller et al., 2003; Beutin et al., 2005).
The genetic differentiation and subtyping of E. coli serotype
O26:H11 was attempted by sequencing 10 loci for 30 strains
encoding stx1, or both stx1 and stx2 (Gilmour et al., 2005).
Amongst the O26:H11 strains all loci were identical, with
the exception of three alleles of mdh and two alleles of ppk
that each differed by a single point mutation. Notably,
comparative analyses of the mdh, gnd, gcl, ppk, metA, ftsZ,
relA and metG alleles encoded by O26:H11 STEC
cumulatively distinguished this serotype from O157:H7
(Gilmour et al., 2005). The conservation of these loci
between O26:H11 strains, and the genetic distance from the
other E. coli serotypes suggested that sequence-based typing
of additional STEC might reveal serotype-specific alleles. In
this study, additional DNA sequence data at these loci was
obtained fora range ofSTEC anda singlelocuswasobserved
to encode allelic variants correlating to individual STEC
O-serogroups. We therefore present a simple molecular
method for the identification of STEC serogroups, including
both O157 and non-O157 strains.
METHODS
Bacterial strains. STEC strains (Table 1) were obtained from the
reference stocks of the Enteric Diseases Program at the National
Microbiology Laboratory that originated from human sources at
various Canadian provincial health laboratories during 1985–2005, or
were recent clinical isolates obtained from the Alberta Provincial
Laboratory for Public Health (nomenclature XX-YYYY, where XX
generally refers to the year of isolation). During the course of these
studies, five outbreak-associated STEC isolates were provided by Nova
Scotia Public Health, Halifax, Nova Scotia, Canada. Confirmation of
O:H serotype was completed with antisera prepared at the National
Microbiology Laboratory (Ewing, 1986).
PCR and sequencing. Template DNA was prepared by centrifuging
1 ml exponential phase culture grown in brain heart infusion broth,
resuspending the pellet in 1 ml TE buffer (Sigma; 10 mM Tris/HCl,
1 mM EDTA, pH 8.0) and boiling the cells for 15 min. Boiled cells
were pelleted, and the supernatant was removed and used as the DNA
template in PCR.
Oligonucleotide primers used to amplify segments of mdh, gnd, gcl,
ppk, metA, ftsZ, relA and metG are presented in Table 2. PCR was
performed with high fidelity Platinum Taq (Invitrogen), following the
manufacturer’s directions. The thermocycling parameters for ftsZ,
relA and metG included an initial denaturation at 94 uC for 5 min,
35 cycles of denaturation at 94 uC for 40 s, annealing at 50 uC for 45 s
and extension at 68 uC for 45 s, with a final extension at 68 uC for
5 min. The annealing temperature for metA, mdh, gcl and ppk was
58 uC, and 52 uC for gnd. PCR products were purified using the
QIAquick PCR purification kit (Qiagen) and sequenced using the
same primers that generated these amplicons. Sequencing was
performed on an ABI3730 (Applied Biosystems) and the data were
deposited in GenBank with accession nos DQ472524–DQ472651.
Existing genomic sequence data for E. coli O157:H7 EDL933,
O157:H7 Sakai, O6:H1 CFT073 and K-12 (GenBank accession nos
NC_000913, BA000007, NC_002655, NC_004431) was included in
our dataset for each of the above loci. From directed studies against
the gnd locus (Tarr et al., 2000; Paton & Paton, 1999b; Wang et al.,
1998), we included sequence data from O157:H7 and O157:NM
(GenBank accession nos AF176359, AF176358, AF176357, AF176356,
AF176360, AF176361 and AB008676), O113:H2 (AF172324), O111
(AF078736) and non-toxin encoding O157 and O55 (AF176368,
AF176367, AF176366, AF176363, AF176362, AF176369 and
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Strains characterized during outbreak investigations are identified (O).
Seropathotype* Serotype Strain ID SourceD Sequencing
schemed
stx1 stx2 LEE§ Reference
A O157:H7 87-1215 NML 8 loci ++ + Gilmour et al. (2006)
O157:H7 01-8110 NML 4 loci ++ + Gilmour et al. (2006)
O157:H7 05-0958 SK HPL 8 loci 2 ++ Gilmour et al. (2006)
O157:H7 04-4319 SK HPL 4 loci + 2 + Gilmour et al. (2006)
O157:H7 03-2641 AB PLPH 4 loci ++ + Gilmour et al. (2006)
O157:NM 01-6434 AB PLPH 8 loci + 2 + Gilmour et al. (2006)
O157:NM 03-3088 AB PLPH 4 loci ++ + This study
O157:NM 03-5296 AB PLPH 8 loci ++ + Gilmour et al. (2006)
B O26:H11 01-6372 NS PHL 8 loci + 2 + Gilmour et al. (2005)
O26:H11 03-2816 AB PLPH 8 loci + 2 + Gilmour et al. (2005)
O26:H11 05-6544 NS PHL (O) gnd + 2 + This study
O103:H2 99-2076 BCCDC 8 loci + 2 + Gilmour et al. (2006)
O103:H2 04-2446 MB CPL 8 loci + 2 + Gilmour et al. (2006)
O103:H2 01-6102 SK HPL 8 loci + 2 + Gilmour et al. (2006)
O103:H2 03-3967 AB PLPH 4 loci + 2 + This study
O103:H11 04-3973 MB CPL gnd + 2 + Thompson et al. (2005)
O103:H11 06-4464 MB CPL gnd + 2 + This study
O103:H25 03-1028 MB CPL gnd + 2 + Thompson et al. (2005)
O103:H25 03-1030 MB CPL gnd + 2 + Thompson et al. (2005)
O103:H25 04-3972 MB CPL gnd + 2 + Thompson et al. (2005)
O103:H25 03-2444 MB CPL gnd + 2 + Thompson et al. (2005)
O111:NM 03-3991 AB PLPH 4 loci + 2 + Gilmour et al. (2006)
O111:NM 04-3794 MB CPL 8 loci ++ + Gilmour et al. (2006)
O111:NM 98-8338 BCCDC 4 loci + 2 + Gilmour et al. (2006)
O111:NM 00-4748 SK HPL 8 loci ++ + Gilmour et al. (2006)
O111:NM 00-4440 BCCDC 4 loci + 2 + Gilmour et al. (2006)
O111:NM 01-0252 BCCDC 8 loci ++ + Gilmour et al. (2006)
O111:NM 01-1215 BCCDC 8 loci + 2 + Gilmour et al. (2006)
O121:H19 03-2636 AB PLPH 4 loci 2 ++ Gilmour et al. (2006)
O121:H19 03-2642 AB PLPH gnd 2 ++ Gilmour et al. (2006)
O121:H19 03-2832 AB PLPH 8 loci 2 ++ Gilmour et al. (2006)
O121:H19 05-6541 NS PHL (O) gnd 2 ++ This study
O121:H19 05-6542 NS PHL (O) gnd 2 ++ This study
O121:H19 05-6543 NS PHL (O) gnd 2 ++ This study
O121:H19 00-5288 BCCDC 8 loci 2 ++ Gilmour et al. (2006)
O145:NM 03-4699 AB PLPH 8 loci + 2 + Gilmour et al. (2006)
O145:NM 04-7099 MB CPL gnd + 2 + This study
O145:NM 04-7194 MB CPL gnd + 2 + This study
O145:NM 04-1449 MB CPL gnd + 2 + This study
O145:NM 03-6430 MB CPL gnd + 2 + Thompson et al. (2005)
O145:NM 02-5149 BCCDC gnd + 2 + This study
C O5:NM 03-2825 AB PLPH 8 loci + 2 + Gilmour et al. (2006)
O5:NM 03-2682 MB CPL gnd + 2 + Thompson et al. (2005)
O91:H21 85-489 NML 8 loci 2 + 2 Gilmour et al. (2006)
O113:H21 93-0016 NML 8 loci 2 + 2 Gilmour et al. (2006)
O113:H21 04-1450 MB CPL gnd 2 + 2 Thompson et al. (2005)
O121:NM 99-4389 NML 8 loci 2 ++ Gilmour et al. (2006)
O121:NM 03-4064 AB PLPH 4 loci 2 ++ This study
O165:H25 00-4540 BCCDC 8 loci 2 ++ Gilmour et al. (2006)
D O6:H34 03-5166 MB CPL gnd 2 + 2 Thompson et al. (2005)
O45:H2 05-6545 NS PHL gnd + 2 + This study
O45:H2 04-2445 MB CPL gnd + 2 + Thompson et al. (2005)
O55:H7 05-0376 NML gnd + 2 + This study
O85:H1 03-3638 AB PLPH 4 loci 2 + 2 This study
M. W. Gilmour and others
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O26:H6 and O26:H32 strains were also included (GenBank
accession nos AY973395–AY973421; Gilmour et al., 2005).
Bioinformatics. Multiple sequence alignments were completed using
ClustalW (www.ebi.ac.uk/clustalw/), neighbour-joining trees were
constructed with Hasegawa–Kishino–Yano (HKY85) distance correc-
tion using SplitsTree4 (Huson, 1998), and genetic diversity statistics
were calculated using DnaSP 4.10.3 (Rozas et al., 2003). Pairwise
global alignments were calculated using Align (www.ebi.ac.uk/
emboss/align/#).
RESULTS AND DISCUSSION
Sequence typing correlates to O-antigen
serogroups
The alleles of mdh, gnd, gcl, ppk, metA, ftsZ, relA and metG
encoded by O26:H11 STEC cumulatively distinguished
this serotype from O157:H7 (Gilmour et al., 2005), and
the corresponding segments of these loci were sequenced
for STEC serotypes O111:NM, O113:H21, O157:NM,
O145:NM, O91:H21, O121:H19, O121:NM, O103:H2,
O165:H25 and O5:NM. This panel of STEC strains
included isolates from each of the most predominant O-
serogroups and O:H-serotypes observed in Canada
(Gilmour et al., 2005, 2006), and amongst individual
serotypes, strains with different stx genotypes were
included when available (Table 1). This sequence dataset
was compared to previously published sequence data for
STEC serotypes O157:H7 and O26:H11, as well as non-
toxin producing O26:H32, O26:H6, K12 and O6:H1
(strain CFT073) strains using the 4464 nucleotide con-
catenate of the eight genetic determinants (Fig. 1). Each of
the examined serogroups had distinct sequence types,
including NM STEC strains of O121 and O157, were 99.8
and 99.9% identical to O121:H19 and O157:H7 strains,
respectively. The observed phylogenetic separation between
serogroups, and homogeneity within strains of the same
serogroup, indicated that these genetic traits have been
acquired by and vertically inherited within individual
STEC serogroup lineages.
Molecular-based serogrouping with four loci
Additional sequencing was performed at selected loci in an
expanded panel of strains to determine if the phylogenetic
separation observed between serogroups was maintained in
a larger dataset (Table 1). The genetic determinants that
contributed the majority of the observed genetic diversity
(gnd and gcl; Table 3) or encoded putative serogroup-
specific regions (ppk and relA; data not shown) were
selected for further study. This panel included further
Seropathotype* Serotype Strain ID SourceD Sequencing
schemed
stx1 stx2 LEE§ Reference
O115:H18 03-3645 AB PLPH 4 loci ++ 2 This study
O117:H7 05-0379 NML gnd + 22 This study
O117:H7 02-0035 BCCDC gnd + 22 This study
O117:H7 02-4495 BCCDC gnd ++ 2 This study
O146:H21 02-7808 BCCDC gnd + 22 This study
O146:H21 02-1628 BCCDC gnd + 22 This study
O177:NM 03-3974 AB PLPH 4 loci 2 ++ This study
O177:NM 06-5121 NS PHL (O) gnd 2 ++ This study
NA O1:H7 03-3964 AB PLPH 4 loci 22 2 This study
O2:H4 03-2815 AB PLPH 4 loci 22 2 This study
O4:H5 03-3266 AB PLPH 4 loci 22 2 This study
O6:H1 03-2638 AB PLPH 4 loci 22 2 This study
O8:H19 03-2639 AB PLPH 4 loci 22 2 This study
O25:H1 03-2637 AB PLPH 4 loci 22 2 This study
O26:H6 01-5872 MB CPL 8 loci 22 2 Gilmour et al. (2005)
O26:H32 99-4328 SK HPL 8 loci 22 2 Gilmour et al. (2005)
O51:NM 04-2640 MB CPL gnd 22 2 This study
O91:H10 03-3269 AB PLPH 4 loci 22 2 This study
O98:NM 02-7464 NB PHL gnd 22 2 This study
O117:H25 02-0714 NB PHL gnd 22 2 This study
*NA, Not applicable. Strains that do encode stx are not classified in the seropathotype scheme (Karmali et al., 2003).
DAB PLPH, Alberta Provincial Laboratory for Public Health; BCCDC, British Columbia Centre for Disease Control; MB CPL, Manitoba Cadham
Provincial Laboratory; NML, National Microbiology Laboratory standard strain; NB PHL, New Brunswick Public Health Laboratory; NS PHL,
Nova Scotia Public Health Laboratory; SK HPL, Saskatchewan Health Provincial Laboratory.
dDNA sequencing was performed for 8 loci (mdh, gnd, gcl, ppk, metA, ftsZ, relA and metG), 4 loci (gnd, gcl, ppk and relA) or solely the gnd locus.
§As determined by PCR screening for the espZ gene (Gilmour et al., 2006).
Table 1. cont.
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seropathotype D and non-toxin encoding E. coli strains
recovered from paediatric stool samples (L. Chui, unpub-
lished data). The overall genetic distinction between STEC
serogroups (as determined in the eight locus scheme) was
also represented amongst these four loci, and the
additional strains and serogroups (Fig. 2).
Molecular-based serogrouping with the gnd locus
The gnd locus was the most genetically diverse of all
examined loci (Table 3), and notably, this determinant is
immediately adjacent to the O-antigen gene cluster.
Additional sequencing of the 643 bp region of gnd was
performed (Table 1), and gnd sequence data available in
GenBank for O157, O113 and O111 STEC, as well as non-
toxin encoding O157 and O55 strains, were also included
in comparative analyses. In total, gnd DNA sequences were
collected from 144 strains and 26 O-serogroups (compris-
ing 42 O:H-serotypes). The overall genetic distinction
between serogroups (as determined in the eight and four
loci schemes) was also represented in this single locus, as
each examined STEC O-serogroup encoded a unique gnd
allele (Fig. 3). For some of the most clinically significant
STEC serogroups (O157, O26, O121, O145, O111 and
O103) the gnd DNA sequences were compared between
multiple strains (from 5 to 43 sequences), and for each
serogroup all STEC strains encoded an identical gnd allele
(Fig. 3). The only exception was O157:H7 strain 87-16
(GenBank accession no. AF176360), which encoded a
Fig. 1. Phylogeny of the concatenated seg-
ments of mdh, gnd, gcl, ppk, metA, ftsZ, relA
and metG encoded by E. coli. This is based
upon a neighbour-joining tree constructed with
Hasegawa–Kishino–Yano (HKY85) distance
correction. Sequences obtained from
GenBank are identified in Methods. The
serotype of strain K-12 was not designated,
and the serotype of uropathogenic strain
CFT073 was O6:K2:H1. Shiga toxin-produ-
cing serotypes are indicated in black type, and
strains not encoding stx are indicated in grey.
The number of sequences per serotype is
indicated in parentheses. Bar, scale of the
distance score.
Table 2. Oligonucleotides used in this study
Oligonucleotide Target Sequence (5§ to 3§) Product size (bp) Reference
GIL213 ftsZ GATCACTGAACTGTCCAAGCATG 450 Gilmour et al. (2005)
GIL214 ftsZ TCAAGAGAAGTACCGATAACCAC
gcl-F gcl GCGTTCTGGTCGTCCGGGTCC 758 Adiri et al. (2003)
gcl-R gcl GCCGCAGCGATTTGTGACAGACC
gnd-F gnd GGCTTTAACTTCATCGGTAC 712 Noller et al. (2003)
gnd-R gnd TCGCCGTAGTTCAGATCCCA
mdh-F mdh CAACTGCCTTCAGGTTCAGAA 580 Noller et al. (2003)
mdh-R mdh GCGTTCTGGATGCGTTTGGT
metA-F metA CGCAACACGCCCGCAGAGC 601 Adiri et al. (2003)
metA-R metA GCCAGCTCGCTCGCGGTGTATT
GIL219 metG TGGCTGACCCGCAGTTGTAC 503 Gilmour et al. (2005)
GIL220 metG GGTCAACTTTGGCGAAGTCGTC
ppk-F ppk TGCCGCGCTTTGTGAATTTACCG 758 Adiri et al. (2003)
ppk-R ppk CCCCGGCGCAGAGAAGATAACGT
GIL215 relA TCTGTTTCCTCCGAACAGGTCG 470 Gilmour et al. (2005)
GIL216 relA ACAATACGTACCGCACGCACATC
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O157 strains, but otherwise the gnd alleles were conserved
within STEC serogroup classifications. Furthermore, non-
toxin encoding strains of O157, O26, O55, O6 and O117
encoded distinct gnd alleles compared to STEC strains of
the same serogroup. Sequence typing of gnd was, therefore,
a promising molecular method correlating minimally with
the O-serogroup of clinical STEC strains. The O111:NM
STEC and non-toxin-producing O55 strains encoded gnd
sequences outlying from the main cluster (Fig. 3) and these
were homologous to Citrobacter spp. gnd alleles (Nelson &
Selander, 1994). However, since pure bacterial isolates are
preferred for preparation of DNA sequencing template, all
isolates undergoing gnd DNA sequence-based serogrouping
should previously be classified as STEC.
During the course of this study, outbreak-related isolates of
non-O157 STEC were sent to the National Microbiology
Laboratory for serotyping and genetic characterization. The
gnd sequence data for each of isolates 05-6541 to 05-6543
clustered with known O121 strains (Fig. 3). A concurrent
non-O157 sporadic isolate (05-6544) was also examined at
gnd and this sequence clustered with known O26:H11
strains (Fig. 3). Strain 06-5121 was isolated from a
hospitalized patient with haemolytic uraemic syndrome
and the gnd sequence of this strain was 99.8% identical to a
known O177:NM isolate (Fig. 3). In correlation with these
molecular data, subsequent serotyping using traditional
methodologies characterized these isolates as O121:H19,
O26:H11 and O177:NM. The gnd DNA sequence-based
serogrouping method therefore provided an advantageous
alternative to O-specific immunoreagents during these
crises. Over 55 serogroups of STEC have been reported to
be associated with human disease (Johnson et al., 2006),
and an international panel of STEC strains from each
serogroup, including the emerging sorbitol-fermenting
O157, will be required to further validate this method.
The proportion of synonymous and nonsynonymous
mutations was calculated for each locus from the accu-
mulated DNA sequence data (Table 3). As expected for
core loci, the majority of mutations were synonymous (dN/
dS ,1), but the gnd locus had the greatest number of
nonsynonymous sites. This locus has already been
identified as a polymorphic E. coli locus compared to
other core loci (Bisercic et al., 1991; Nelson & Selander,
1994; Dykhuizen & Green, 1991). A comparable ratio of
synonymous versus nonsynonymous mutations was also
reported by Bisercic et al. (1991). Genetic diversity at gnd
arose in parallel to the extensive diversity and recombina-
tion that occurred at the neighbouring O-antigen gene
cluster, and it is likely that these two genetic traits were
Fig. 2. Phylogeny of the concatenated segments of gnd, gcl, ppk and relA encoded by E. coli. This is based upon a neighbour-
joining tree constructed with Hasegawa–Kishino–Yano (HKY85) distance correction. Sequences obtained from GenBank are
identified in Methods. Shiga toxin-producing serotypes are indicated in black type, and strains not encoding stx are indicated in
grey. The number of sequences per serotype is indicated in parentheses. Bar, scale of the distance score.
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http://jmm.sgmjournals.org 625Fig. 3. Phylogeny of the gnd locus encoded by E. coli. This is based upon a neighbour-joining tree constructed with
Hasegawa–Kishino–Yano (HKY85) distance correction. Sequences obtained from GenBank are identified in Methods. Shiga
toxin-producing serotypes are indicated in black type, and strains not encoding stx are indicated in grey. The number of
sequences per serotype is indicated in parentheses. Strain identification numbers are indicated for outbreak-associated clinical
isolates. The dotted line indicates outlying gnd sequences, which are presented in relation to the entire dataset in the inset. Bar,
scale of the distance score.
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Selander, 1994). To our knowledge, there is no indication
that O-serogroups that encode similar gnd alleles (e.g.
STEC O121 and O55) also encode similar O-antigen gene
clusters, nor are the antigens themselves similar. The
potential utility of a locus subject to recombination
between genera might be seemingly limited for the purpose
of molecular-based serogrouping; however, we currently
observed conserved STEC serogroup-specific genetic poly-
morphisms at the gnd locus. Between strains of an
individual STEC O-serogroup we observed conserved gnd
alleles, and no serogroup encoded a gnd allele that was
identical to another serogroup. This study provides a
simple method for molecular-based serogrouping of E. coli
strains encoding stx, which can be detected by a wealth of
molecular reagents (Gilmour et al., 2006; Hsu et al., 2005;
Nielsen & Andersen, 2003; Reischl et al., 2002; Wang et al.,
2002). This method was used to characterize O121:H19,
O26:H11 and O177:NM clinical isolates prior to serolo-
gical confirmation during an outbreak investigation, and
could, therefore, improve the scope of STEC molecular
diagnostics beyond the O157 serogroup.
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